| Condition | Utility | |-----------|---------| | Traumatic Brain Injury | Attention, memory, and executive deficits. | | Dementia (Alzheimer’s, Frontotemporal, Vascular) | Differentiate subtypes; track decline. | | Epilepsy (esp. temporal lobe) | Lateralizing memory deficits. | | Stroke | Localization of cognitive deficits. | | Schizophrenia / Bipolar disorder | Cognitive remediation planning. | | Mental retardation / Learning disability | Cognitive profile for rehabilitation. |
The NIMHANS Battery is widely used for:
If you are presenting a PPT on this battery, end with a powerful clinical pearl: nimhans neuropsychological battery ppt
"The NIMHANS battery is not a rigid 'test battery' in the Luria-Nebraska sense. It is a flexible approach. The skilled clinician uses the battery as a hypothesis-testing tool. If a patient fails the CTT due to poor vision, you don't diagnose 'attention deficit.' Interpret patterns, not single scores. And always—always—compare performance to the patient's premorbid baseline using the NII." | Condition | Utility | |-----------|---------| | Traumatic
| Condition | Utility | |-----------|---------| | Traumatic Brain Injury | Attention, memory, and executive deficits. | | Dementia (Alzheimer’s, Frontotemporal, Vascular) | Differentiate subtypes; track decline. | | Epilepsy (esp. temporal lobe) | Lateralizing memory deficits. | | Stroke | Localization of cognitive deficits. | | Schizophrenia / Bipolar disorder | Cognitive remediation planning. | | Mental retardation / Learning disability | Cognitive profile for rehabilitation. |
The NIMHANS Battery is widely used for:
If you are presenting a PPT on this battery, end with a powerful clinical pearl:
"The NIMHANS battery is not a rigid 'test battery' in the Luria-Nebraska sense. It is a flexible approach. The skilled clinician uses the battery as a hypothesis-testing tool. If a patient fails the CTT due to poor vision, you don't diagnose 'attention deficit.' Interpret patterns, not single scores. And always—always—compare performance to the patient's premorbid baseline using the NII."